QUEENSBURY, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of innovative medical devices used by interventional radiologists, nephrologists and surgeons for the minimally invasive treatment of cancer and peripheral vascular disease, announced today that it has appointed Michael S. Sharp, Ph.D., 59, as the Company’s Vice President, Regulatory, Quality and Clinical Affairs. Dr. Sharp will report to William Appling, Senior Vice President for Advanced Research and Development at AngioDynamics.
